This paper is in the following e-collection/theme issue:

Web-based and Mobile Health Interventions (4018) User-Centered Design Case Studies (713) Design and Formative Evaluation of Mobile Apps (809) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1732) mHealth in a Clinical Setting (743) Innovations and Technology in Cancer Care (531) Mobile Apps for Cancer Care and Cancer Prevention and Screening (265)

Published on in Vol 22, No 5 (2020): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/15895, first published .
The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach

The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach

The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach

Authors of this article:

Geneviève ICG Ector1 Author Orcid Image ;   Peter E Westerweel2 Author Orcid Image ;   Rosella PMG Hermens3 Author Orcid Image ;   Karin AE Braspenning3 Author Orcid Image ;   Barend CM Heeren4 Author Orcid Image ;   Oscar MF Vinck5 Author Orcid Image ;   Jan JM de Jong6 Author Orcid Image ;   Jeroen JWM Janssen7 Author Orcid Image ;   Nicole MA Blijlevens1 Author Orcid Image
Article Authors Cited by (34) Tweetations (4) Metrics

Geneviève ICG Ector   1 , MSc, MD ;   Peter E Westerweel   2 , MD, PhD ;   Rosella PMG Hermens   3 , PhD ;   Karin AE Braspenning   3 , MSc ;   Barend CM Heeren   4 , MSc ;   Oscar MF Vinck   5 , MSc ;   Jan JM de Jong   6 , MSc, MD ;   Jeroen JWM Janssen   7 , MD, PhD ;   Nicole MA Blijlevens   1 , MD, PhD

1 Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands

2 Department of Hematology, Albert Schweitzer Hospital, Dordrecht, The Netherlands

3 Department of IQ Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands

4 REshape Innovation Center, Radboud University Medical Center, Nijmegen, The Netherlands

5 Patient advisor, No affiliations, Nijmegen, The Netherlands

6 Dutch Patient Advocacy Group 'Hematon', Utrecht, The Netherlands

7 Department of Hematology, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam University Medical Centers,, Amsterdam, The Netherlands

Corresponding Author:

  • Geneviève ICG Ector, MSc, MD
  • Department of Hematology
  • Radboud University Medical Center
  • Geert Grooteplein Zuid 8
  • Nijmegen 6500 Hb
  • The Netherlands
  • Phone: 31 243618810
  • Fax: 31 243635163
  • Email: genevieve.ector@radboudumc.nl